WO2023031881 - COMPOSITIONS AND METHODS FOR TREATING LONG QT SYNDROME
National phase entry:
Publication Number
WO/2023/031881
Publication Date
09.03.2023
International Application No.
PCT/IB2022/058286
International Filing Date
02.09.2022
Title **
[English]
COMPOSITIONS AND METHODS FOR TREATING LONG QT SYNDROME
[French]
COMPOSITIONS ET MÉTHODES DE TRAITEMENT DU SYNDROME DU QT LONG
Applicants **
UNIVERSITY OF BERN
Verwaltungsdirektion
Hochschulstrasse 6
3012 Bern, CH
Inventors
LI, Jin
Buehlstrasse 28
3012 Bern, CH
Priority Data
63/240,494
03.09.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1402 | |
| EPO | Filing, Examination | 6623 | |
| Japan | Filing | 588 | |
| South Korea | Filing | 574 | |
| USA | Filing, Examination | 4510 |
Total: 13697 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present disclosure provides anti-KCNQ1 monoclonal antibodies and their use in treating long QT syndrome (LQTS).[French]
La présente invention concerne des anticorps monoclonaux anti-KCNQ1 et leur utilisation dans le traitement du syndrome du QT long (LQTS).